The global osteoarthritis pain medicine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The market growth is driven by the increasing prevalence of arthritis and the surge in the number of sports injuries. Among the types of osteoarthritis pain medicines, hand osteoarthritis medicines are likely to see a major boost in the future years owing to the constantly growing cases. The hand is the most frequently affected part of the body by osteoarthritis, which results in excessive pain and inability to properly function of hand or wrist. Osteoarthritis of the hand is most likely to develop in people falling in the age group of 40 to 70. As per the Arthritis Foundation, in the US, nearly 54.4 million adults (22.7% of all adults) had doctor-diagnosed arthritis during the period, 2013-2015. By 2040, an estimated adult aged 18 years and older with doctor-diagnosed arthritis will be 78.4 million (25.9% of the estimated total adult population) in the US. Osteoarthritis is the most common form of arthritis.
To Request a Sample of our Report on Osteoarthritis Pain Medicine Market: https://www.omrglobal.com/request-sample/osteoarthritis-pain-medicine-market
There are various forms of medicines available such as analgesics, that are used for pain treatment. This drug class works by stopping signals in the body that creates pain. Instances of analgesics include Acetaminophen (Tylenol) and Duloxetine (Cymbalta). Acetaminophen (Tylenol) is an over-the-counter (OTC) analgesic that can be administered orally as a tablet, gel capsule, or liquid concentration. Another class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) is also used for the treatment of osteoarthritis pain. Moreover, a rise in healthcare-related spending along with awareness related to osteoarthritis is likely to open up new avenues of growth of the global osteoarthritis pain medicine market during the forecast period.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Johnson & Johnson Services, Inc., and GlaxoSmithKline plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Osteoarthritis Pain Medicine Market is Available @ https://www.omrglobal.com/industry-reports/osteoarthritis-pain-medicine-market
Global Osteoarthritis Pain Medicine Market Report by Segment
By Product
- Oral
- Injection
Global Osteoarthritis Pain Medicine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
